Tectonic Therapeutic (TECX) Gains from Investment Securities (2017 - 2018)
Tectonic Therapeutic's (TECX) quarterly Gains from Investment Securities came in at $150000.0 in Q2 2018, up 1150.0% on a QoQ basis from $12000.0 in Q1 2018.
Tectonic Therapeutic (TECX) Gains from Investment Securities (2017 - 2018) Analysis & Trends
Tectonic Therapeutic (TECX) has 2 years of Gains from Investment Securities data on file, last reported at $150000.0 in Q2 2018.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to $150000.0 in Q2 2018; TTM through Sep 2019 was $150000.0, a 13.29% decrease from a year earlier, with the FY2018 full-year figure at $162000.0, up 852.94% from the prior year.
- Gains from Investment Securities for Q2 2018 stood at $150000.0, up from $12000.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for TECX reached as high as $150000.0 in Q2 2018 and fell as low as $6000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Tectonic Therapeutic | 575.46 Mn | 575.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 150,000.00 |
| Jun 30, 2018 | 150,000.00 |
| Mar 31, 2018 | 12,000.00 |
| Mar 31, 2018 | 12,000.00 |
| Dec 31, 2017 | 11,000.00 |
| Dec 31, 2017 | 11,000.00 |
| Sep 30, 2017 | 6,000.00 |
| Sep 30, 2017 | 6,000.00 |